Latest News for DuPont de Nemours (DD) Investors

Large-cap industrials company DuPont de Nemours has moved 0.5% this morning, reaching $73.68 per share. In contrast, the average analyst target price for the stock is $81.29.

DuPont de Nemours, Inc. provides technology-based materials and solutions in the United States, Canada, the Asia Pacific, Latin America, Europe, the Middle East, and Africa. The company is based in the United States. DuPont de Nemours currently returns an annual dividend yield of 1.9%.

Make Sure to Consider the Following Before Buying DuPont de Nemours:

  • DuPont de Nemours has moved -2.2% over the last year.

  • DD has a forward P/E ratio of 18.7 based on its EPS guidance of 3.95.

  • Over the last 6 years, earnings per share (EPS) have been growing at a compounded average rate of 63.4%.

  • The company has a price to earnings growth (PEG) ratio of 2.08.

  • Its Price to Book (P/B) ratio is 1.31

DuPont de Nemours Has Generally Positive Cash Flows

Date Reported Cash Flow from Operations ($ k) Capital expenditures ($ k) Free Cash Flow ($ k) YoY Growth (%)
2023 722,000 715,000 7,000 104.52
2022 588,000 743,000 -155,000 -111.15
2021 2,281,000 891,000 1,390,000 35.08
2020 1,301,000 272,000 1,029,000 1044.04
2019 1,383,000 1,492,000 -109,000 -103.13
2018 4,731,000 1,244,000 3,487,000

The company's free cash flows are strong in the aggregate, since they average out to $941.5 Million over the last 6 years. The compounded average growth rate for this period stands at -66.6% with a year-on-year growth variability coefficient of 299.61%.

The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.